Moderna Gets Fed. Circ. To Affirm Ax Of MRNA Patent
A small medical startup failed Tuesday to convince the Federal Circuit that language in one of its patents that purportedly covers an mRNA delivery system used in the COVID-19 vaccine was...To view the full article, register now.
Already a subscriber? Click here to view full article